Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ADCY3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
EDC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP210 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RALGPS1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MFSD8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSME3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED28 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COX7C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
CUL3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WHSC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CERS2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALNT18 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MIF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP48 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR26 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FRYL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CYLD - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on